Literature DB >> 27312437

Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?

Christina M Wyatt1, Daniel C Cattran2.   

Abstract

Posttrial follow-up of participants randomized to intensive versus standard glycemic control in the ADVANCE trial has demonstrated a significant benefit of intensive glycemic control on the risk of end-stage renal disease. In a more detailed analysis, intensive glycemic control appears to be of benefit only before the development of clinically evident kidney disease or in patients with documented early-stage chronic kidney disease.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27312437     DOI： 10.1016/j.kint.2016.05.002

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  4 in total

1.  CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease.

Authors:  Khurrum Shahzad; Sameen Fatima; Moh'd Mohanad Al-Dabet; Ihsan Gadi; Hamzah Khawaja; Saira Ambreen; Ahmed Elwakiel; Nora Klöting; Matthias Blüher; Peter P Nawroth; Peter R Mertens; Sven Michel; Frank Jaschinski; Richard Klar; Berend Isermann
Journal:  J Am Soc Nephrol       Date:  2021-09-03       Impact factor: 10.121

2.  Kidney cytosine methylation changes improve renal function decline estimation in patients with diabetic kidney disease.

Authors:  Caroline Gluck; Chengxiang Qiu; Sang Youb Han; Matthew Palmer; Jihwan Park; Yi-An Ko; Yuting Guan; Xin Sheng; Robert L Hanson; Jing Huang; Yong Chen; Ae Seo Deok Park; Maria Concepcion Izquierdo; Ioannis Mantzaris; Amit Verma; James Pullman; Hongzhe Li; Katalin Susztak
Journal:  Nat Commun       Date:  2019-06-05       Impact factor: 14.919

3.  Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression.

Authors:  Moh'd Mohanad Al-Dabet; Khurrum Shahzad; Ahmed Elwakiel; Alba Sulaj; Stefan Kopf; Fabian Bock; Ihsan Gadi; Silke Zimmermann; Rajiv Rana; Shruthi Krishnan; Dheerendra Gupta; Jayakumar Manoharan; Sameen Fatima; Sumra Nazir; Constantin Schwab; Ronny Baber; Markus Scholz; Robert Geffers; Peter Rene Mertens; Peter P Nawroth; John H Griffin; Maria Keller; Chris Dockendorff; Shrey Kohli; Berend Isermann
Journal:  Nat Commun       Date:  2022-08-27       Impact factor: 17.694

Review 4.  New strategies to improve clinical outcomes for diabetic kidney disease.

Authors:  Thomas Forst; Chantal Mathieu; Francesco Giorgino; David C Wheeler; Nikolaos Papanas; Roland E Schmieder; Atef Halabi; Oliver Schnell; Marina Streckbein; Katherine R Tuttle
Journal:  BMC Med       Date:  2022-10-10       Impact factor: 11.150
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.